The biological component uses forebrain organoids derived from human induced pluripotent stem cells.
The specific problem FinalSpark seeks to tackle is the high-energy demands of training and running large artificial neural networks.
But this advantage will likely only be realized in the long term.

Right now, FinalSpark has granted free access to nine institutions for research use only.